IFN-beta gene transfer into the central nervous system using bone marrow cells as a delivery system.
IFN-beta gene transfer into the central nervous system using bone marrow cells as a delivery system.
复制标题
使用骨髓细胞作为传递系统将 IFN-β 基因转移到中枢神经系统。
DOI:
10.1089/107999002320271378
复制
发表时间:
2002
期刊:
影响因子:
--
通讯作者:
Dhib-Jalbut,Suhayl
中科院分区:
文献类型:
--
作者:
Makar,TapasKumar;Wilt,Susan;Dong,Zhongyun;Fishman,Paul;Mouradian,MMaral;Dhib-Jalbut,Suhayl
The peripheral delivery of interferon-β(IFN-β) for the treatment of central nervous system (CNS) diseases is only partially effective because of the blood-brain barrier (BBB). To circumvent this problem, we evaluated the feasibility of genetically altering bone marrow cellsex vivoand using them as vehicles to transfer the IFN-βcDNA into the mouse CNS. An IFN-βretroviral expression vector (pLXSN-IFNβ) was used to stably transfect PA317 cells. The supernatant from these producer cells, which expressed IFN-βmRNA and protein, were used to infect bone marrow cells. When transplanted into irradiated mice, IFN-β-engineered marrow cells accessed the CNS and expressed IFN-βmRNA and protein. Marrow cells transduced with a control neomycin vector entered the brain and expressed the neomycin but not the IFN-βgene. In the CNS, IFN-βdelivered by marrow cells induced the mRNA expression of 2′,5′-oligoadenylate synthetase (2′,5′-OAS), indicating biologic activity. Our findings demonstrating that bone marrow cells can serve as a delivery system for IFN-βcDNA into the CNS could have implications for the treatment of neurologic disorders, such as multiple sclerosis (MS), viral encephalitis, and brain tumors.